Algeta to present at Cowen’s 30th Annual Health Care Conference - Trading Markets (press release)
Alpharadin is partnered with AG, a major pharmaceutical company, and is in a global phase III clinical trial (ALSYMPCA) to treat bone
Источник:
2010-03-04
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL